Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy: Results From the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

✍ Scribed by Rossignol, P.; Dobre, D.; McMurray, J. J. V.; Swedberg, K.; Krum, H.; van Veldhuisen, D. J.; Shi, H.; Messig, M.; Vincent, J.; Girerd, N.; Bakris, G.; Pitt, B.; Zannad, F.

• Book ID: 127298189
• Publisher: Ovid Technologies Wolters Kluwer -American Heart Association
• Year: 2014
• Tongue: English
• Weight: 786 KB
• Volume: 7
• Category: Article
• ISSN: 1941-3289
• DOI: 10.1161/circheartfailure.113.000792